Close
Loading...
CONTACT US
:
:
:
Call us at:
:
:
:
Fax:
Email:

CD300A

Products

Loading...

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

Background

CD300A, encoded by the CD300A gene located at human chromosome 17q25.1, is a single-pass type I transmembrane receptor of the immunoglobulin superfamily. Its extracellular region contains a single immunoglobulin-like V-type domain, and its cytoplasmic tail carries immunoreceptor tyrosine-based inhibitory motifs (ITIMs). The protein has a calculated molecular weight of approximately 33 kDa, and it is expressed on a range of immune cells, including natural killer cells, T cells, B cells, and myeloid cells. Rather than activating immune responses, CD300A functions as an inhibitory receptor that transmits negative signals upon ligand engagement. It binds the aminophospholipids phosphatidylethanolamine and phosphatidylserine, which are exposed on the surface of apoptotic and activated cells, and its ligation recruits the SHP-1 and SHP-2 phosphatases to suppress immune cell activation.

CD300A is an inhibitory receptor that participates in the negative regulation of immune cell responses. Its ITIM-mediated signaling inhibits natural killer cell cytotoxicity, B cell and T cell receptor signaling, and mast cell degranulation, and it modulates the engulfment of apoptotic cells by myeloid cells. Through these activities, CD300A contributes to the control of immune homeostasis and the resolution of inflammation, making it a useful target for research on inhibitory receptor signaling, apoptotic cell recognition, and immune regulation.

Fig. 1 Schematic depicting the molecular architecture of human CD300A and CD300C. (OA Literature)Fig. 1 Schematic representation of the molecular structure of human CD300A and CD300C.1

CD300A Protein Function: Roles in Inhibitory Immune Regulation and Apoptotic Cell Recognition

CD300A, encoded by the CD300A gene, functions as an inhibitory immune receptor that suppresses immune cell activation in response to aminophospholipid ligands:

  • Aminophospholipid Recognition: CD300A binds phosphatidylethanolamine and phosphatidylserine, aminophospholipids that become exposed on the outer leaflet of apoptotic and activated cells.
  • Inhibitory Signaling: Ligand engagement of CD300A induces phosphorylation of its cytoplasmic ITIMs and recruitment of the SHP-1 and SHP-2 phosphatases, which dampen immune cell activation.
  • Natural Killer Cell Regulation: CD300A inhibits natural killer cell cytotoxicity and antibody-dependent cellular cytotoxicity, contributing to the control of natural killer cell effector functions.
  • Lymphoid and Myeloid Regulation: CD300A signaling also modulates B cell and T cell receptor signaling, mast cell degranulation, and the engulfment of apoptotic cells by myeloid cells.
  • Structure-Function Relationship: The single extracellular immunoglobulin-like domain and the ITIM-containing cytoplasmic tail of CD300A provide a basis for investigating how ligand recognition is coupled to intracellular inhibitory signaling.

CD300A Protein Product

Creative Biolabs offers high-quality CD300A proteins produced using optimized expression systems, including full-length receptor and isolated extracellular domain variants. The CD300A extracellular domain directly mediates aminophospholipid binding, making these proteins suitable for ligand-receptor interaction studies and related molecular characterization. Studies of CD300A inhibitory signaling require appropriate systems containing the cytoplasmic ITIM motifs and associated phosphatases. All CD300A proteins undergo strict quality control to support consistent performance across applicable research platforms.

Custom CD300A Protein Product

Not finding the protein product you need? Contact us to start your one-stop custom service!

CD300A Stable Cell Line Product

Creative Biolabs provides custom-engineered CD300A stable cell lines, including overexpression and blank control models. These cell lines are optimized for studies of inhibitory receptor signaling and immune cell regulation. Each cell line undergoes stringent validation to ensure stable expression profiles and consistent functional performance in diverse experimental contexts.

CD300A Stable Cell Line Product

Not finding the stable cell line product you need? Contact us to start your one-stop custom service!

CD300A Recombinant Antibody Product

High-specificity recombinant antibodies targeting CD300A are developed using antibody engineering technologies for research applications involving CD300A expression and localization. These antibodies can be used in studies of CD300A distribution on immune cells and may also support characterization of CD300A ligand interactions in combination with appropriate aminophospholipid detection reagents.

CD300A Recombinant Antibody Product

Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!

Product Features

  • Aminophospholipid Binding Activity: Supports investigation of phosphatidylethanolamine and phosphatidylserine recognition.
  • CD300A Specificity: Provides reagents directed against the inhibitory receptor without cross-recognizing other CD300 family members.
  • Immune Regulation Research Compatibility: Optimized reagent series for inhibitory receptor signaling and immune cell regulation research workflows.
  • Comprehensive Customization Support: Facilitates end-to-end development of customized proteins, antibodies and stable cell lines to address immune regulation research demands.

Custom CD300A Research Services

Beyond catalog products, Creative Biolabs offers specialized custom services for CD300A research:

  • Custom CD300A Protein Production: Tailored expression of full-length, mutant, and tagged CD300A constructs for ligand binding and signaling analysis.
  • Custom Antibody Development: Generation of CD300A-specific antibodies for detection of the inhibitory receptor on immune cells.
  • Stable Cell Line Engineering: Construction of CD300A-modified cell models for inhibitory receptor signaling research.
  • Functional Assay Development: Custom design of ligand binding, phosphatase recruitment, and immune cell regulation detection workflows.

Frequently Asked Questions (FAQs)

  1. What is the primary function of CD300A?

    CD300A is an inhibitory immune receptor that binds the aminophospholipids phosphatidylethanolamine and phosphatidylserine and suppresses immune cell activation through ITIM-mediated signaling.

  2. Why is CD300A a significant research target?

    CD300A is a core inhibitory receptor controlling natural killer cell, B cell, T cell, and myeloid cell responses, and studying it informs the molecular mechanisms of inhibitory signaling and apoptotic cell recognition.

  3. Are Creative Biolabs' CD300A products suitable for clinical use?

    No, all CD300A products and services are strictly for research use only, not intended for clinical diagnosis or treatment.

  4. What types of CD300A products does Creative Biolabs offer?

    Offerings include full-length CD300A proteins, custom CD300A stable cell lines, and CD300A-specific recombinant antibodies for inhibitory immune receptor research.

  5. What research applications are CD300A products suitable for?

    CD300A products are suitable for studies of aminophospholipid binding, inhibitory receptor signaling, apoptotic cell recognition, and immune cell regulation.

Reference
  1. Dias, Carolina, Francesca Levi-Schaffer, and Pedro Jose Esteves. "Evolutionary analysis of CD300A and CD300C paired receptors in primates." Frontiers in Immunology 16 (2025): 1633323. Under Open Access license CC BY 4.0, without modification. https://doi.org/10.3389/fimmu.2025.1633323
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us
© 2026 Creative Biolabs. | Contact Us
Thanksgiving Sale - up to 20% off membrane proteins and stable cell lines
Membrane Proteins Stable Cell Lines
;